Next Article in Journal
Effects of Modifying Thioflavin T at the N3-Position on Its G4 Binding and Fluorescence Emission
Next Article in Special Issue
Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model
Previous Article in Journal
Anti-Obesity Attributes; UHPLC-QTOF-MS/MS-Based Metabolite Profiling and Molecular Docking Insights of Taraxacum officinale
Previous Article in Special Issue
Investigation of Dextran-Coated Superparamagnetic Nanoparticles for Targeted Vinblastine Controlled Release, Delivery, Apoptosis Induction, and Gene Expression in Pancreatic Cancer Cells
Open AccessReview

Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs

Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia
*
Author to whom correspondence should be addressed.
Academic Editors: Krešimir Pavelić and Sandra Kraljević Pavelić
Molecules 2020, 25(21), 4937; https://doi.org/10.3390/molecules25214937
Received: 2 October 2020 / Revised: 23 October 2020 / Accepted: 24 October 2020 / Published: 26 October 2020
(This article belongs to the Special Issue Translational Approach to Antitumor Drugs)
The circadian rhythms are an intrinsic timekeeping system that regulates numerous physiological, biochemical, and behavioral processes at intervals of approximately 24 h. By regulating such processes, the circadian rhythm allows organisms to anticipate and adapt to continuously changing environmental conditions. A growing body of evidence shows that disruptions to the circadian rhythm can lead to various disorders, including cancer. Recently, crucial knowledge has arisen regarding the essential features that underlie the overt circadian rhythm and its influence on physiological outputs. This knowledge suggests that specific small molecules can be utilized to control the circadian rhythm. It has been discovered that these small molecules can regulate circadian-clock-related disorders such as metabolic, cardiovascular, inflammatory, as well as cancer. This review examines the potential use of small molecules for developing new drugs, with emphasis placed on recent progress that has been made regarding the identification of small-molecule clock modulators and their potential use in treating cancer. View Full-Text
Keywords: circadian rhythm; biological clock; cancer; small molecules; anticancer drugs circadian rhythm; biological clock; cancer; small molecules; anticancer drugs
Show Figures

Figure 1

MDPI and ACS Style

Rahman, S.; Wittine, K.; Sedić, M.; Markova-Car, E.P. Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs. Molecules 2020, 25, 4937. https://doi.org/10.3390/molecules25214937

AMA Style

Rahman S, Wittine K, Sedić M, Markova-Car EP. Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs. Molecules. 2020; 25(21):4937. https://doi.org/10.3390/molecules25214937

Chicago/Turabian Style

Rahman, Sadia; Wittine, Karlo; Sedić, Mirela; Markova-Car, Elitza P. 2020. "Small Molecules Targeting Biological Clock; A Novel Prospective for Anti-Cancer Drugs" Molecules 25, no. 21: 4937. https://doi.org/10.3390/molecules25214937

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop